Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays by Oldridge, Derek A. et al.
Optimizing copy number variation analysis using
genome-wide short sequence oligonucleotide arrays
Derek A. Oldridge
1, Samprit Banerjee
2, Sunita R. Setlur
3, Andrea Sboner
4 and
Francesca Demichelis
1,5,*
1Department of Pathology and Laboratory Medicine,
2Department of Public Health, Weill Cornell Medical
College, 1305 York Avenue, Y 1307 (or box no. 140), NY 10065,
3Department of Pathology, Brigham and
Women’s Hospital and Harvard Medical School, Boston, MA 02115,
4Molecular Biophysics and Biochemistry
Department, Yale University, New Haven, CT 06520 and
5Institute for Computational Biomedicine, Weill Cornell
Medical College, 1305 York Avenue, Y 1307 (or box no. 140), NY 10065, USA
Received October 12, 2009; Revised January 21, 2010; Accepted January 25, 2010
ABSTRACT
The detection of copy number variants (CNV) by
array-based platforms provides valuable insight
into understanding human diversity. However,
suboptimal study design and data processing neg-
atively affect CNV assessment. We quantitatively
evaluate their impact when short-sequence oligo-
nucleotide arrays are applied (Affymetrix Genome-
Wide Human SNP Array 6.0) by evaluating 42
HapMap samples for CNV detection. Several
processing and segmentation strategies are imple-
mented, and results are compared to CNV assess-
ment obtained using an oligonucleotide array CGH
platform designed to query CNVs at high resolution
(Agilent). We quantitatively demonstrate that differ-
ent reference models (e.g. single versus pooled
sample reference) used to detect CNVs are a
major source of inter-platform discrepancy (up to
30%) and that CNVs residing within segmental dupli-
cation regions (higher reference copy number) are
significantly harder to detect (P<0.0001). After
adjusting Affymetrix data to mimic the Agilent
experimental design (reference sample effect), we
applied several common segmentation approaches
and evaluated differential sensitivity and specificity
for CNV detection, ranging 39–77% and 86–100% for
non-segmental duplication regions, respectively,
and 18–55% and 39–77% for segmental duplica-
tions. Our results are relevant to any array-based
CNV study and provide guidelines to optimize per-
formance based on study-specific objectives.
INTRODUCTION
Single nucleotide polymorphisms (SNPs) and copy
number variants (CNVs) are two important components of
genomic variation underlying much of human phenotypic
diversity. CNVs, recently discovered to exist on a large
scale (1,2), are unbalanced rearrangements (e.g. deletions,
duplications), operationally deﬁned as segments of DNA
larger than 1kb in size which are present in diﬀerent
numbers of copies between individuals (3–5). CNVs are
currently estimated to encompass between 6 and 10%
of the human reference genome assembly (Database
of Genomic Variants (DGV), http://projects.tcag.ca/
variation/) (5,6). The extent to which this common
source of variation exists in the human genome is not
yet known, due to its incomplete characterization.
However, its contribution in the ﬁeld of evolution (7–9)
and disease susceptibility (10) has been demonstrated in
the past few years.
When dealing with the detection of CNV loci and with
the assessment of individuals’ copy number states, one
level of complexity arises from the lack of an ideal refer-
ence genome; a reference genome is necessary in order
to quantify the copy number signal of each individual
under study. Another level of complexity when using
genome-wide array approaches is deﬁning the appropriate
balance between extracting reliable information from
the data and maximally exploiting the available informa-
tion (i.e. speciﬁcity versus sensitivity) or applying multiple
strategies to separately address false positive and false
negative rates. In addition, complex genomic regions (seg-
mental duplications, tandem repeats, architecturally
complex CNVs) require special attention to obtain
accurate characterization.
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are SNP arrays or hybrid arrays implementing short
sequence oligonucleotide probes (e.g. Aﬀymetrix and
Illumina use 25- and 50-mers) and long sequence oligo-
nucleotide arrays implementing comparative genome
hybridization (CGH) (e.g. Agilent, Nimblegen). The
former use short base-pair sequences to capture fragments
of DNA and use hybridization intensities to infer
copy number without the need of a reference sample
cohybridized with the target sample. One advantage of
this approach is that it allows for determination
of genotypes of SNPs. On the other hand, CGH arrays
are known to provide a more accurate determination
of DNA copy number due in part to optimization
of genomic hybridization (11,12). CGH arrays gener-
ally utilize two samples for each experiment in order to
empirically compare the amount of DNA present in one
sample (target) to a single sample or pooled reference
(reference).
The current study identiﬁes problems and suggests
possible solutions when dealing with genome-wide array
studies involving the characterization of CNVs. Based on
a set of 42 individual samples from the HapMap consor-
tium, we present a comparative study of CNV detection
by the Aﬀymetrix Genome-Wide Human SNP Array
6.0 platform using previously published data from a
custom CNV-targeted CGH platform from Agilent as
our standard for comparison. Brieﬂy, the Aﬀymetrix
Genome-Wide 6.0 SNP platform comprises 907K
probes for detecting SNPs in addition to 946K non-
SNP probes of which 140K probes speciﬁcally target
CNV regions. The custom designed Agilent array set
comprises 470K probes, speciﬁcally designed for CNV
detection (13). We assess the eﬀects of probe cross-
hybridization, of diﬀerent reference models used to
quantify the array signal at time of data processing, and
of diﬀerent data segmentation approaches on CNV assess-
ment for Aﬀymetrix SNP 6.0 data after replicating the
Agilent single reference sample setting. For our seg-
mentation analysis, we apply three commonly used data
processing algorithms to detect copy number changes
(14,15) (http://www.aﬀymetrix.com/partners_programs/
programs/developer/tools/powertools.aﬀx). Although the
speciﬁc performance numbers that we report reﬂect the
present study design, we focus on observations and
results that are conceptually applicable to any CNV
oriented study.
MATERIALS AND METHODS
Sample selection
All samples considered in this study come from the
International HapMap Project (16). For marker QC
analysis, data was considered from 270 HapMap individ-
uals, consisting of 30 trios from Utah residents of
European ancestry (CEU), 30 trios from the Yoruba in
Ibadan, Nigeria (YRI), 45 unrelated Japanese in Tokyo
(JPT), and 45 unrelated Han Chinese in Beijing (CHB).
For cross platform comparison, a 30 sample subset of
these 270 individuals was selected (see Supplementary
Table S1), including 10 unrelated CEU, 10 unrelated
YRI, 5 unrelated JPT and 5 unrelated CHB individuals.
This sample set reﬂects the study from Perry et al. (13).
An additional 12 HapMap samples proﬁled using the
Agilent Technologies Human Genome CNV microarray
set (G4423B, AMADIDs 018897 and 018898) were
considered.
Comparative genomic hybridization data
Data for the 30 HapMap samples analyzed with the
custom Agilent array set considered in Perry et al. were
obtained from the Gene Expression Omnibus under acces-
sion number GSE9831. Sample NA10851 was used as the
reference sample. Data preprocessing is described in ref.
(13). An additional 12 HapMap samples were analyzed
using a similar data analysis workﬂow; sample NA15510
was used as a reference. See Supplementary Methods
section.
Short sequence oligo-nucleotide data
Raw HapMap data generated using the Aﬀymetrix
Genome-Wide Human SNP Array 6.0 were obtained
from Aﬀymetrix (Aﬀymetrix, Santa Clara, CA). Raw
data was preprocessed according to the Aﬀymetrix CN5
method included in Aﬀymetrix Power Tools (APT)
(http://www.aﬀymetrix.com/partners_programs/programs
/developer/tools/powertools.aﬀx). Similar to Perry et al.
(13), Aﬀymetrix marker sequence alignment against the
human genome reference sequence (hg18) was performed
to identify all locations with perfect (25-mer) and imper-
fect (23–24-mer) matches. Only markers which map to a
single perfect match and fewer than four 24-mer match
locations were retained for CNV detection analysis.
Brieﬂy, a total of 15631 such SNP markers (out of
Table 1. Summary statistics for positive copy number deviations (gains) called by segmentation of Aﬀymetrix data across the entire genome
Algorithm Parameters Gain count mean Gain size (bp) Gain marker count Gain log2 intensity ratio
Mean Median SD Mean Median SD Mean Median SD
CBS  =0.002 69 59543 7615 176276 38 18 112 1.06 0.73 0.72
CBS (Default)  =0.010 82 53922 6815 165482 34 15 98 1.03 0.74 0.69
CBS  =0.010, sdundo=2 52 22266 4082 131444 17 6 133 1.35 1.25 0.68
CBS  =0.050 127 40620 4665 140259 24 8 73 0.99 0.80 0.62
GLAD (Default) d=6 91 34713 2785 141832 24 4 104 1.43 1.31 0.83
GLAD d=12 53 59608 5152 189243 39 8 136 1.50 1.49 0.88
HMM (Default) 116 51617 8046 361000 26 11 77 0.97 0.75 0.60
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were excluded according to these criteria. Markers
residing within segmental duplications were more likely
to fail the above criteria than those which do not reside
within segmental duplications (OR=15.6, P<210
16).
Importantly, of the 41730 markers annotated as residing
within segmental duplication regions (UCSC annotation
as of November 2009), only 9366 (22.4%) are ﬂagged for
exclusion based on the above marker alignment analysis,
indicating that many segmental duplication markers
remain in order to detect copy number variation at seg-
mental duplication loci (see Supplementary Data in
Supplementary Methods section). For more detail on
platform design and sequence alignment and marker
response evaluation, see Supplementary Data in
Supplementary Methods section.
Reference models
Aﬀymetrix log2 intensity ratio data was considered
with respect to one of two possible references: (i) a 210
parental HapMap reference model (built on a marker
basis by taking the median values across the 210 samples)
or(ii)asinglesamplereference basedoneitherNA10851or
NA15510, to reﬂect the original Agilent CGH array data.
Transformation of log2 ratio data from the original
multiple sample reference model to a single sample refer-
ence takes advantage of the following logarithmic
identity: log2(Target/210HapMap)log2(SingleSample/
210HapMap)=log2(Target/SingleSample).
Data segmentation
Three commonly used segmentation algorithms were
applied to the Aﬀymetrix data. Gain and Loss Analysis
of DNA (GLAD, R package from Bioconductor) (14) was
applied with d equal to 6 (default) and to 12 (d controls
the penalty of adding markers to a segment). Circular
Binary Segmentation (CBS, ‘DNAcopy’ package from
Bioconductor) (15) was applied with  =0.002, 0.010
(default), and 0.050. A Hidden Markov Model (HMM)
approach was applied using the HMM algorithm provided
in the standard APT workﬂow with default parameters.
RESULTS
Segmentation results
We evaluated the summary statistics for the count, size in
terms of base pairs and number of markers, and amplitude
of gain and deletion deviations produced by segmentation
of Aﬀymetrix across 42 HapMap samples (see Tables 1
and 2). Upper and lower bounds of ±0.15 were applied
for distinguishing real copy number gain and loss from no
change, respectively. Notably, CBS with  =0.050 and
HMM tend to generate the largest number of gain
segments, with an average of 127 and 116 gains per
individual, respectively, whereas CBS with  =0.010 and
sdundo=2, and GLAD with d=12 generate the fewest,
with 52 and 53 average gains, respectively. A similar trend
is observed for deletions, where CBS with  =0.050
and HMM generate 160 and 168 deletions per individ-
ual, respectively, whereas CBS with  =0.010 and
sdundo=2, and GLAD with d=12 generate the
fewest, with 75 and 68 deletions, respectively. Across algo-
rithms, median gain sizes range from 2.8 to 8kb and from
4 to 18 markers, whereas median deletion sizes range from
1.3 to 4.4kb and from 3 to 6 markers. Median log2 inten-
sity ratio amplitude varies from 0.73 to 1.49 for gains and
from 1.00 to 1.65 for deletions. Average segment size
and amplitude are generally inversely correlated with the
number of segments that are called.
Performance measures: false negative and false
positive rate
False negative rates (FNR) and false positive rates (FPR)
for segmented Aﬀymetrix SNP 6.0 data are deﬁned in ref-
erence to the sample level CNVs determined by Agilent
aCGH, which we consider our ‘gold standard’ for com-
parison. We deﬁned a false negative as a CNV reported in
Agilent data that is not detected as a copy number devi-
ation by segmentation of Aﬀymetrix data, and FNR is the
proportion Agilent CNVs which are not concordantly
detected on the Aﬀymetrix platform, evaluated on
a sample basis. Analogously, a false positive is a copy
number deviation determined from segmentation of
Aﬀymetrix data that does not correspond to an Agilent
CNV, and FPR is the proportion of Aﬀymetrix copy
number deviations which are not concordantly reported
in the Agilent data, evaluated on a sample basis.
Only Aﬀymetrix segments of 10 or more markers and
an absolute mean log2 intensity ratio of 0.15 or more are
considered to be signiﬁcant copy number deviations for
evaluating FNR and FPR. To account for diﬀerential
genomic coverage of the Aﬀymetrix and Agilent plat-
forms, only Agilent CNVs with at least 10 markers of
Aﬀymetrix overlap are considered when calculating
Table 2. Summary statistics for negative copy number deviations (deletions) called by segmentation of Aﬀymetrix data across the entire genome
Algorithm Parameters Deletion count mean Deletion size (bp) Deletion marker count Deletion log2 intensity ratio
Mean Median SD Mean Median SD Mean Median SD
CBS  =0.002 83 58029 4280 214436 22 7 47 1.27 1.28 0.69
CBS (Default)  =0.010 100 49885 3787 191598 20 6 42 1.21 1.19 0.67
CBS  =0.010, sdundo=2 75 15748 2085 73529 10 3 27 1.45 1.44 0.59
CBS  =0.050 160 36158 2947 166297 14 4 34 1.13 1.09 0.60
GLAD (Default) d=6 119 29512 1348 153514 13 3 39 1.45 1.42 0.69
GLAD d=12 68 52372 1711 224355 21 3 55 1.62 1.65 0.74
HMM (Default) 168 28379 4360 112994 13 6 29 1.23 1.00 0.71
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at least ﬁve markers of Agilent coverage are considered
when calculating FPR. Supplementary Table S2 reports
the statistics of the number of segments and CNVs
included in each analysis. When determining sample
level concordance between the Aﬀymetrix deviation
proﬁle and the Agilent CNV proﬁle, we apply an
overlap criterion for a CNV to be considered concordantly
detected by both the Aﬀymetrix and Agilent platforms.
When calculating FNR (FPR), at least 50% of the
overlapping Aﬀymetrix (Agilent) probes must be called
as Aﬀymetrix copy number deviations (Agilent CNVs),
with concordant direction. This overlap criteria based on
the percentage of probes as opposed to size percentage
takes uneven marker spacing into consideration between
the two platforms.
FNR and FPR are evaluated on an algorithmic basis
in order to assess performance in terms of sensitivity
and speciﬁcity for detecting CNV. In addition to consid-
ering the overall performances, we considered vari-
ous subcategories of CNVs deﬁned by the number of
markers or by the average log2 ratios in order to assess
the eﬀects of CNV size, direction and amplitude on per-
formance. Speciﬁcally, for FNR, we subdivided by CNVs
with 2–4, 5–10, or 11 Agilent probes; by deletion CNVs
with mean log2 ratio 0.75, or >0.75 and 0.15; and
by gain CNVs with mean log2 ratio 0.15 and <0.75,
or 0.75. For FPR, we subdivided by CNVs with 10–19,
20–29, or 30 Aﬀymetrix probes; and by deletion and
gain CNVs with mean log2 ratios as for FNR.
Correction methods to account for reference model/sample
Before presenting the FNR and FPR values for the
direct comparison of Aﬀymetrix versus Agilent data
by simulating the same experimental design, we quanti-
tatively examine the eﬀect of the reference model/sample
on FNR and FPR. A dual channel Agilent aCGH exper-
iment uses a reference based on a single sample or pooled
samples which are co-hybridized with the target sample
during array hybridization, whereas in a single channel
Aﬀymetrix experiment, only the target sample is
hybridized to a given array and a reference model is
computationally applied based on median marker signal
across multiple samples following hybridization. This
diﬀerence is a source of systematic discordance and
reﬂects a general problem introduced in inter-study
CNV data comparison (reference sample/model eﬀect).
For example, in a single reference sample design, a
deletion in the single sample reference would result in
the appearance of a copy number gain in any target
samples with no copy number change at that locus,
and it would appear as if there was no copy number
change for any target samples which show the same
deletion (Figure 1A). On the other hand, for low to
moderate CNV frequency, a multiple sample median
reference model would correctly reﬂect the no copy
number change state as the reference state and allow for
correct evaluation of the target sample state (Figure 1B
and C).
We considered three methods to correct for systematic
copy number proﬁle discordance due to reference diﬀer-
ences; the ﬁrst approach is a stringent and simple utiliza-
tion of CNV frequency information (does not require the
availability of the raw data), the second one utilizes
the Agilent single channel data (raw data needed), and
the third one transforms the Aﬀymetrix data to mimic
the Agilent experimental design (requires availability of
single reference sample Aﬀymetrix data). The results are
summarized in Figure 2.
Frequency-based approach. In general, rare CNVs present
in the single sample reference will lead to an unusually
high number of target samples showing the ‘opposite’
CNV state. We set a frequency threshold of 66% and
then ran the comparison on the remaining 93.6% of CNV
loci (2759) from Perry et al. (13). On a sample level, this
stringent criterion resulted in 56% of CNV exclusion for
FNR evaluation and in 28–74% of CNV exclusion for
FPR. The frequency based approach is very simple and
does not require speciﬁc data processing; however, it dra-
matically reduces the number of loci for inter-study
comparison.
Agilent single channel approach. Single channel signal
intensities were analyzed to select all Agilent detected
CNVs where the reference sample is estimated to have
two copies. For each CNV and each experiment, we
compute the median reference channel signal intensity
across all probes that fall in this CNV. The histogram
of these median intensities is shown in Supplementary
Figure S3. The ﬁrst three peaks on the signal intensity
distribution correspond to zero, one and two copies, and
we conservatively estimate that the reference sample has
two copies in CNVs with median signal intensities ranging
between 450 and 700 counts. Only these CNVs were used
for comparison with Aﬀymetrix data.
Single sample reference model for Aﬀymetrix
data. Aﬀymetrix data are computationally transformed
to mimic the Agilent single reference sample design
(either NA10851 or NA15510 based on the original
Agilent data, see ‘Materials and Methods’ section).
This correction method does not exclude any CNV
regions in the FNR or FPR analysis. The transformed
Aﬀymetrix data are re-segmented, and FNR and FPR
are considered as speciﬁed above based on the new
Aﬀymetrix copy number deviation proﬁle determined by
segmentation.
Figure 2 shows FNR and FPR performance of these
three correction methods with respect to the uncorrected
FNR and FPR. Notably, both the frequency-based
approach and the agilent single channel approach led to
improved FNR (44 and 52%, respectively, relative to
65% uncorrected) and FPR (38 and 33%, respectively,
relative to 42% uncorrected). However, the best perfor-
mance is observed by simply transforming the Aﬀymetrix
data so that its implicit reference is in agreement with the
Agilent data (37% FNR and 20% FPR, nearly half of the
uncorrected rates).
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Figure 1. Impact of the reference model copy number data for sample NA10839 at polymorphic locus chr4:9823254–9844366 (Variation_38803
from DGV, in red) and ﬂanking areas (in black), as obtained by three diﬀerent approaches. Top: Dual channel Agilent data. By design, sample
NA10851 was used as reference (single sample reference). NA10839 appears to have no change in copy number. This is a spurious eﬀect, due to the
presence of homozygous deletions at Variation_38803 in both NA10839 and NA10851. An increased signal-to-noise ratio is appreciable within the
polymorphic locus, where the root mean square of the log2 ratio is 3.97 times higher than the ﬂanking areas. Middle: Single channel Aﬀymetrix data.
Hybridization intensity data of sample NA10839 is analyzed with respect to NA10851 data (single sample reference). Like the top panel, NA10839
appears to have no change in copy number at Variation_33803. The root mean square of the log2 ratio within the polymorphic locus is 1.25 times
higher with respect to the ﬂanking areas. Bottom: Single channel Aﬀymetrix data. Hybridization intensity data of sample NA10839 is analyzed with
respect to a multi-sample reference model based on the median signal across 210 parental HapMap. The log2 intensity data shows the deletion at
Variation_33803. The median value across the markers within the polymorphic locus is 1.36.
Nucleic Acids Research, 2010,Vol.38, No. 10 3279It is important to note that single sample reference
based analyses of Aﬀymetrix data is commonly performed
in the context of paired tumor-versus-normal analysis, but
is rarely applied in the context of germline CNV assess-
ment. However, in the context of our study design, this
last approach directly removes the confounding eﬀect of
diﬀerent reference models used for our Aﬀymetrix versus
Agilent comparison and allows us to more accurately
assess segmentation algorithm performance without the
need to exclude CNV regions, which would limit the
scope of our FNR and FPR analysis. Therefore, all
further FNR and FPR analysis is performed with the
Aﬀymetrix log2 intensity ratio data transformed to the
appropriate single sample reference.
Segmental duplication regions
Segmental duplication regions are known to be enriched
for deletion and duplication events, especially mediated by
non-allelic homologous recombination (NAHR) and are
therefore of interest in CNV studies. However, segmental
duplication regions are more diﬃcult to handle and need
dedicated attention (6,17). In fact, it becomes more diﬃ-
cult to distinguish a one copy change in the target data,
since the expected log2 intensity ratio decreases as a
function of increasing reference copy number. We illus-
trate this theoretical decrease in signal schematically in
Figure 3A [e.g. a one copy gain at a segmental duplication
is harder to detect since log2(5/4)<log2(3/2)]. We empiri-
cally evaluated the distribution of marker level log2
intensity ratios across 270 HapMap samples at known
CNVs considered in McCarroll et al. (4) (Figure 3B–E),
distinguishing between segmental duplication and
non-segmental duplication regions. Annotation of seg-
mental duplications was obtained from the UCSC
Genome Browser. As expected, the signal distribution dif-
ferentiation among diﬀerent copy number states is
reduced in segmental duplication regions, especially for
copy number losses (P-value<210
16, for CN=0, 1
and 3; P-value=0.0027, for CN=4). This suggests that
the assessment of CNV states within segmental duplica-
tion regions requires speciﬁc thresholds and needs to
be treated separately from non-segmental duplication
regions.
Supplementary Table S3 includes the summary statis-
tics of non-segmental duplication CNVs included in
the analysis per segmentation approach. Supplementary
Table S4 summarizes the average per sample counts of
CNVs detected by the Aﬀymetrix and Agilent platforms,
per every CNV subcategory considered in this study.
Comparison of CNV detection approaches
In this section we separately report on the analysis of
non-segmental duplication and segmental duplication
regions and discuss the main diﬀerences. Detailed compar-
ison of CNV detection approaches is summarized in
Tables 3 and 4. For non-segmental duplication regions,
CBS with  =0.050 and HMM exhibit the greatest
overall sensitivity (23% FNR), whereas GLAD and CBS
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Figure 2. Correction methods for evaluating FNR and FPR. FNR and FPR evaluated by comparing Aﬀymetrix copy number deviation proﬁles
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frequency method is better for FNR and the reference channel method is better for FPR. However, simply transforming the Aﬀymetrix reference to
be in agreement with the single sample reference implicit in the Agilent data yields the lowest FNR and FPR, and therefore the highest concordance
between the Aﬀymetrix and Agilent platforms. All segmented Aﬀymetrix data are obtained from the CBS algorithm with  =0.010, though the same
qualitative result is observed for the other segmentation algorithms which we consider.
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Figure 3. Schematic and empirical data of log2 intensity ratios in the context of segmental duplication and non-segmental duplication regions.
(A) Schematic of log2 intensity ratios for one copy number change CNVs with respect to diﬀerent reference states. Red vertical arrows indicate the
diﬀerences between copy neutral reference and segmental duplicate (seg-dup) reference for one copy loss (left panel) and one copy gain (right panel).
(B–E) Distribution of log2 intensity ratios for Aﬀymetrix SNP 6.0 Array markers within knwn polymorphic CNV loci, distinguishing between
segmental duplication annotated regions (colored red) and non-segmental duplication regions (colored blue). Data is considered from the subset of
270 HapMap samples showing copy number variation with respect to a copy neutral (CN=2) median reference at each CNV locus. The cases of
homozygous deletion (CN=0, panel B), hemizygous deletion (CN=1, panel C), one copy gain (CN=3, panel D), or two copy gain (CN=4,
panel E) are assessed independently based on sample level CN state calls reported in McCarroll et al. Vertical red and blue lines identify the medians
of the distributions. In the case of homozygous deletion (CN=0), markers which reside within segmental duplication regions exhibit a median log2
intensity ratio of 0.90, whereas those markers which do not reside within segmental duplication regions exhibit a median log2 intensity ratio of
1.68 (P<210
16). For the case of hemizygous deletions, the median log2 intensity ratio values are 0.34 versus 0.45, respectively
(P<210
16); for one copy gain, 0.26 versus 0.29, respectively (P<210
16); and for two copy gain, 0.46 versus 0.47, respectively
(P=0.0027). Overall, markers residing within segmental duplication regions exhibit less sensitivity to detect copy number variation, as indicated
by a smaller absolute median log2 intensity ratio for each case considered.
Nucleic Acids Research, 2010,Vol.38, No. 10 3281with sdundo=2 exhibit the lowest (61% FNR) (Table 3).
Across subcategories, the best performances are seen for
high amplitude gains or deletions (absolute log2 intensity
ratio>0.75) where FNR ranges 10–50% across algo-
rithms. Signiﬁcantly poorer performance is seen in the
2–4 Agilent marker, small CNV category (50–90%
FNR) and in the low amplitude gain (40–90% FNR)
and low amplitude loss categories (75–100% FNR). As
expected, there is a trend toward lower FNR with
increasing CNV size and amplitude. There is also a
trend toward lower FNR as the CBS parameter,  ,
increases, or as the GLAD parameter, d, decreases, con-
sistent with their expected eﬀects on sensitivity. Though
CBS is generally more sensitive than GLAD, it is note-
worthy that running CBS with parameter sdundo=2
yields similar performance to GLAD. A summary
of FNR performance evaluated across all algorithms,
parameters, subcategories, and samples considered, for
non-segmental duplication CNVs, is compiled in
Figure 4A.
The trend for overall FPR is essentially the reverse of
overall FNR, where CBS with  =0.050 and HMM show
the lowest speciﬁcity (12% FPR), and GLAD or CBS
with sdundo=2 show the highest (nearly 0% FPR)
(Table 4). The most speciﬁc algorithms perform with
100% or near 100% speciﬁcity across all CNV categories.
For algorithms with non-zero FPR, speciﬁcity typically
ranges 80–90% across subcategories. One important
comment is that FPR is lower than FNR across nearly
all CNV subcategories regardless of algorithm, indicating
that the sensitivity associated with these algorithms does
not incur a large penalty to speciﬁcity. However, CBS with
 =0.050 and HMM do show nearly twice the FPR
associated with CBS with  =0.002. When FPR is
greater than zero, there is an apparent trend towards
lower FPR with increasing CNV size and amplitude.
Similar to the results for FNR, running CBS with
sdundo=2 yields comparable FPR performance to
GLAD. A summary of FPR performance evaluated
across all algorithms, parameters, subcategories, and
samples considered, for non-segmental duplication
CNVs, is compiled in Figure 4B.
Lower performance is observed for segmental duplica-
tion CNVs, where FNR increases 9–27% and FPR
increases 12–24% relative to the results considered for
non-segmental duplication CNVs (Tables 3 and 4).
However, the relative ranking of segmentation algorithms
based on sensitivity and speciﬁcity is otherwise unchanged
and similar trends based upon CNV size and amplitude
are observed. One notable exception for FNR is in the 11
or more Agilent marker, large CNV category, where
higher FNR is observed relative to the 5–10 Agilent
marker, medium-sized CNV category. This observation
is consistent with the presence of large segmental duplica-
tion CNVs which are detected at low-amplitude by the
Agilent platform due to a higher associated reference
copy number. Comparing segmental duplication and
non-segmental duplication CNVs, FNR increases in the
11 or more Agilent marker category by 20–30% across
algorithms, and it is this category that drives the overall
increase in FNR. There is a statistically signiﬁcant diﬀer-
ence (Wilcoxon test, P<0.05) between overall FNR
evaluated for segmental duplication CNVs versus
non-segmental duplication CNVs across all algorithms.
FPR comparisons across algorithms are also signiﬁcantly
diﬀerent (Wilcoxon test, P<0.05). The graphical repre-
sentation of FNR and FPR performance evaluated
across all algorithms, parameters, subcategories and
Table 3. Evaluation of diﬀerence between FNR calculated separately for segmental duplication and non-segmental duplication CNVs
Algorithm Parameters FNR for segmental duplication CNVs FNR for non-segmental duplication CNVs P-value
Median Lower 95% Upper 95% Median Lower 95% Upper 95%
CBS  =0.002 0.53 0.34 0.79 0.28 0.06 0.59 1.02E09
CBS (Default)  =0.010 0.50 0.32 0.77 0.26 0.08 0.55 2.46E10
CBS  =0.010, sdundo=2 0.82 0.64 0.92 0.61 0.29 0.85 7.12E09
CBS  =0.050 0.45 0.27 0.74 0.23 0.10 0.48 4.77E10
GLAD (Default) d=6 0.68 0.48 0.86 0.55 0.31 0.80 0.000201
GLAD d=12 0.70 0.46 0.86 0.61 0.34 0.82 0.004025
HMM (Default) 0.50 0.36 0.76 0.23 0.06 0.44 5.74E13
Table 4. Evaluation of diﬀerence between FPR calculated separately for segmental duplication and non-segmental duplication CNVs
Algorithm Parameters FPR for segmental duplication CNVs FPR for non-segmental duplication CNVs P-value
Median Lower 95% Upper 95% Median Lower 95% Upper 95%
CBS  =0.002 0.29 0.05 0.50 0.06 0.00 0.13 6.17E12
CBS (Default)  =0.010 0.32 0.05 0.49 0.10 0.00 0.20 7.45E12
CBS  =0.010, sdundo=2 0.15 0.00 0.43 0.03 0.00 0.15 3.95E06
CBS  =0.050 0.36 0.10 0.49 0.14 0.05 0.29 3.28E10
GLAD (Default) d=6 0.24 0.03 0.52 0.03 0.00 0.09 1.69E13
GLAD d=12 0.23 0.04 0.50 0.00 0.00 0.10 8.37E14
HMM (Default) 0.33 0.05 0.64 0.11 0.02 0.25 2.35E09
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Figure 4. (A) FNR for non-segmental duplication CNVs. FNR evaluated by comparing Aﬀymetrix copy number deviation proﬁles with an Agilent
gold-standard across 42 HapMap samples, considering only non-segmental duplication CNVs. Overall and across nearly all subcategories, CBS with
 =0.050 and HMM exhibit the greatest sensitivity, whereas CBS with  =0.010 and sdundo=2 and GLAD with d=12 exhibit the least.
Nucleic Acids Research, 2010,Vol.38, No. 10 3283samples considered, for segmental duplication CNVs
alone, is compiled in Supplementary Figures S4 and S5.
In summary, we ﬁnd that diﬀerent combinations of seg-
mentation algorithms and their associated parameters
yield a range of speciﬁcities and sensitivities for detecting
copy number variation. Although tuning algorithm-
speciﬁc parameters has slight eﬀects on sensitivity and
speciﬁcity, CBS and HMM are inherently more sensitive
for detecting copy number variation whereas GLAD is
inherently more speciﬁc. However, merging segments
based on a standard deviation threshold after CBS seg-
mentation yields results which are comparable to GLAD,
indicating that post-segmentation processing can be used
when greater speciﬁcity is desired. Although no algorithm
and parameter set is able to detect even a simple majority
of small CNVs with relatively poor Aﬀymetrix marker
coverage or low amplitude CNVs, CBS and HMM will
perform comparatively better than GLAD in detecting
such low-signal CNVs. On the other hand, we ﬁnd that
the GLAD algorithm is inherently more conservative
when calling copy number segments, with near zero
FPR across all CNV categories considered in this study.
GLAD may therefore be best suited for applications
where speciﬁcity is at a premium. The appropriate seg-
mentation algorithm will largely depend on the particular
needs of the application at hand.
DISCUSSION
Ongoing studies aimed at CNV characterization, assess-
ment of disease/phenotype association and evolutionary
investigation rely on array-based approaches. DGV
collects and organizes the data generated in the research
community related to CNVs and insertions and deletions.
It is widely used in the genomic community both to
retrieve information on a speciﬁc region or CNV from
multiple studies and to retrieve genome-wide information
from one or more studies for comparison purposes.
Inter-study comparisons are delicate due to multiple
factors related to diﬀerent platforms and experimental
designs. In particular, diﬀerences in platform spatial reso-
lution (inter-marker distance), dynamic range, reference
model, platform strengths and weaknesses must all be
taken into account together with the study data processing
approaches. Furthermore, complex genomic regions such
as segmental duplications, tandem repeats, and complex
CNV areas require special attention. In addition, the size
and the ethnic background of each study cohort need to
be considered especially when assessing and comparing
CNV frequencies of rare CNVs and low-frequency
polymorphisms (18). A recent paper from Shaikh et al.
(5) showed that the reliable assessment of low frequency
CNVs in healthy individuals (controls) is particularly
crucial when dealing with genotype–phenotype associa-
tion studies.
In the current study, we quantitatively evaluate the
impact of diﬀerent experimental and data processing alter-
natives and choices in the context of CNV detection
and copy number assessment by deﬁning strict perfor-
mance measures when comparing data generated with
a genome-wide short sequence oligonucleotide array
(Aﬀymetrix) with a long sequence oligonucleotide CGH
array custom designed for CNV detection (Agilent). First,
we evaluate the impact of using diﬀerent reference models
(single- versus multi-sample reference model) when
detecting and assessing CNV states; we measure that
implementing diﬀerent reference models in the analysis
pipeline can lead to overall FNR and FPR diﬀerences as
high as 25 and 20%. We suggest that overall a
multi-sample reference model is a preferable solution in
the context of CNV discovery, as it tends to avoid mis-
leading results, such as the absence of a CNV call when
the target and the reference sample both possess the same
CNV state diﬀerent than the normal state (see Figure 1).
The main caveat in using the multi-sample reference
model has to do with assessing the copy number state at
polymorphic loci with moderate to high incidence (around
and above 50%). For instance, a homozygous/hemizygous
deletion in 51% of the population will result in a
multi-sample reference model reﬂecting the deletion,
therefore resulting in no detectable change for each
target sample with the deletion and in a gain for each
target sample with two copies. For known CNV loci,
computational approaches, like ‘Canary’ (19), can circum-
vent the reference model problem by taking advantage of
the relative diﬀerences between adjacent sample signal
clusters, which are independent of the applied reference
model. Due to reference model diﬀerences between
studies, publicly accessible CNV information can be mis-
leading; one example is shown in Supplementary Figure
S6 where a region known to undergo deletions in 40–50%
of Caucasian population is annotated in DGV as harbor-
ing gains in one-third of the available studies, including
the paper from Perry et al. (13). It is interesting to note
that many studies aimed at characterizing the somatic
Figure 4. Continued
As expected, there is a general trend toward lower FNR with increasing CNV size or amplitude, since such CNVs will beneﬁt from an increased
signal-to-noise ratio and will be easier to detect. Comparing CBS and GLAD, the eﬀect of varying the CBS parameter   or the GLAD parameter
have modest eﬀects on FNR in relation to changing algorithms. However, applying the CBS parameter sdundo=2 yields performance which is
comparable with GLAD. (B) FPR for non-segmental duplication CNVs. FPR evaluated by comparing Aﬀymetrix copy number deviation proﬁles
with an Agilent gold-standard across 42 HapMap samples, considering only non-segmental duplication CNVs. Overall and across nearly all
subcategories, CBS with  =0.010 and sdundo=2, and GLAD with d=12 exhibit the greatest speciﬁcity, whereas and CBS with  =0.050 and
HMM exhibit the least, inverting the trend for sensitivity observed in the FNR analysis. There is a general trend toward lower FPR with increasing
Aﬀymetrix copy number deviation size or amplitude. This is expected, because nearly all real CNVs which can be concordantly detected by the two
platforms should be detected by the Agilent platform. Therefore, false positives primarily represent random noise of the Aﬀymetrix platform, and it
is unlikely that progressively larger or higher amplitude copy number deviations will be called by segmentation from random noise. Comparing CBS
and GLAD, the decreased sensitivity of GLAD observed in the FNR analysis is oﬀset somewhat by near perfect speciﬁcity observed for the GLAD
algorithm.
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approaches in the past without experiencing reference
model issues, since germline DNA from the same individ-
ual provides the ideal reference for somatic lesion detec-
tion (20,21).
To ensure the most comparable settings between the
Aﬀymetrix and the Agilent data, we used a single
sample reference model reﬂecting the original data set-up
to evaluate the performance of various data analysis
approaches. We ﬁrst show that segmental duplication
regions are signiﬁcantly harder to process for CNV
detection. Then we demonstrate that diﬀerent analysis
strategies lead to signiﬁcantly diﬀerent performance and
that to achieve both high sensitivity and speciﬁcity in the
detection of copy number using genome-wide array plat-
forms, multiple parallel strategies must be considered.
In terms of sensitivity, the best overall performances
were obtained by HMM and CBS with  =0.05 with
average FNR=0.252±0.101 and 0.261±0.114, respec-
tively. When looking at subcategories of CNVs based on
size and amplitude, we observed that the best FNRs are
obtained for homozygous deletions and high amplitude
gains, despite the CNV size, and that poorer FNRs are
obtained for short CNVs (1–4kb) and for small ampli-
tudes, with CBS with  =0.01 and the ‘undo’ option
scoring the highest FNR. When assessing speciﬁcity, the
best overall performances were scored by GLAD (d=6,
12) and CBS ( =0.010 and ‘undo’ option). Importantly,
GLAD with d=6 detects a higher number of seg-
ments (on average 1.6 times the segments detected by
GLAD with d=12 or by CBS), therefore providing
greater sensitivity with no apparent cost to speciﬁcity
(Tables 1–4).
Comparing the Aﬀymetrix and Agilent platforms, we
investigated to what extent FNR and FPR performances
diﬀer for CNVs overlapping segmental duplication loci
versus CNVs which do not. Importantly, segmental dupli-
cation regions are enriched for deletion and duplication
events, speciﬁcally NAHR. When comparing performance
obtained for segmental duplication regions relative
to non-segmental duplication regions, we consistently
detected overall increases in FNR and FPR across each
algorithm (Wilcoxon test P-values ranging from 810
14
to 410
3). This quantitative comparison supports the
fact that segmental duplication regions are intrinsically
harder to evaluate for CNV detection and assessment,
because the relative signals for copy number diﬀerences
are lower (Figure 3) and that Agilent signal-to-noise
ratio tends to facilitate signal interpretation in complex
regions.
It is worth highlighting that this study assessed CNV
detection performances in a discovery-like fashion. When
dealing with known CNV loci—known coordinates from
previous studies—the assessment of copy number state in
single samples is a completely diﬀerent task. If highly
speciﬁc probes are available, the assessment of single
sample copy number state at known loci can be performed
with as little as one marker. Supplementary Figure S7
shows the distribution of log2 ratios across HapMap
samples included in this study by using single Aﬀymetrix
and Agilent markers (positions chr4:64386072 and
chr4:64381900, respectively) located on a biallelic CNV
(Variation_38050).
In conclusion, this study quantitatively measured the
eﬀect of experimental and analytical choices on CNV
detection and characterization, providing insights into
the highlights and limitations of using short sequence
oligonucleotide arrays. Importantly, short sequence
oligonucleotide arrays allow for the assessment of SNP
genotypes, which can contribute to the overall study,
such as population stratiﬁcation (ethnicity) (22), inter-
sample similarity and identity test (23) and inbreeding
coeﬃcient assessment (24); SNP probe single allele
data can be utilized to validate copy number calls (see
Supplementary Figure S8) (18), and SNP and CNV
probe intensities can be jointly investigated in phenotype
association studies. Although this study focused on data
generated by two platforms (i.e. Aﬀymetrix and Agilent),
we envision that the FNR and FPR result trends we
obtained are generalizable to other platforms and all eval-
uations related to the reference model eﬀect and the seg-
mental duplication regions are conceptually valid and
platform independent. Whereas proper experimental
design and CNV validation by PCR, qPCR, FISH or
sequencing are required for a successful study, a lot can
be done on the analysis side to exploit genome-wide CNV
data and to enhance the sensitivity and speciﬁcity of the
results based upon the goals of an individual study.
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Supplementary Data are available at NAR Online.
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